|Ethical Investment Mid-Cap Model Portfolio update
The Ethical Investment Mid-Cap Model Portfolio ended 2017 with a total return of 11.07% for the year, slightly underperforming the All Ordinaries Index which gained 12.47%.
Strong performers for the year included the healthcare companies Medical Developments International, Integral Diagnostics and CSL which returned 60%, 69% and 41%, respectively.
Other top performers included the investment and superannuation platforms Hub24 and Australian Ethical which gained 85% and 66%, respectively. Blackmores bounced back strongly after a disappointing 2016 with a return of 69% for the year, while the small renewable energy company Genex Power rose 58%.
The main detractors to performance for the year included Murray River Organics which fell 67% and Praemium which dropped 20%. Both of these stocks were sold during the year. Other disappointing returns included the battery manufacturer Redflow which was down 20% and the renewable energy companies Carnegie Clean Energy and Infigen Energy which fell 54% and 31%, respectively.
The Model Portfolio continues to outperform the overall market since its inception, with a return of 9.94% per annum.
Please click here
to view the full Model Portfolio Update.